Medipostincis A Biotechnology Company Based In South Koreafounded In 2000It Specializes In Stem Cell Therapeutics And Regenerative Medicinefocusing On Innovative Treatments For Incurable Diseases Using Umbilical Cord Blood Derived Mesenchymal Stem Cellshucb Mscs The Company Aims To Address Unmet Medical Needs And Has Established Itself As A Leader In The Fieldsecuring Numerous Patents And National R&D Grants The Company S Product Portfolio Includes Cartistema The First Regulatory Approved Allogeneic Hucb Msc Product For Knee Cartilage Defects And Osteoarthritisand Pneumostema A Preventive Treatment For Bronchopulmonary Dysplasia In Preterm Infantsadditionallymedipost Is Developing Therapies Through Its Smup Platformwhich Enhances Cell Selection And Culture Efficiencythe Company Also Offers Cord Blood Storage Services And Is Actively Pursuing Global Expansion With International Patents And Regulatory Approvals
No conferences found for this company.
| Company Name | Medipost America Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
